Organogenesis Holdings (ORGO) Shares Outstanding (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Shares Outstanding (Entity) of $129.4 million for Q1 2026, up 1.43% year-over-year from $127.6 million in Q1 2025, and up 1.35% quarter-over-quarter from $127.7 million in Q4 2025.
Organogenesis Holdings (ORGO) Shares Outstanding (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Shares Outstanding (Entity) history runs 12 years deep, the most recent figure standing at $129.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.43% year-over-year to $129.4 million; the TTM figure through Mar 2026 stood at $129.4 million (up 1.43% YoY), while the FY2025 annual figure was $127.7 million, up 0.97% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $129.4 million, up from $127.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $133.3 million in Q3 2024, with the low at $126.5 million in Q4 2024.
- The 5-year median for Shares Outstanding (Entity) is $131.6 million (2022), against an average of $130.5 million.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) gained 2.02% in 2022, then dropped 4.29% in 2025.
- Organogenesis Holdings' Shares Outstanding (Entity) stood at $131.6 million in 2022, then climbed by 0.3% to $132.0 million in 2023, then decreased by 4.23% to $126.5 million in 2024, then gained by 0.97% to $127.7 million in 2025, then advanced by 1.35% to $129.4 million in 2026.
- Business Quant data shows ORGO's Shares Outstanding (Entity) at $129.4 million in Q1 2026, $127.7 million in Q4 2025, and $127.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Organogenesis Holdings | 242.55 Mn | 195.71 Mn | 20.08 Mn | 128.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 128.67 Mn |
| Mar 31, 2026 | 127.80 Mn |
| Dec 31, 2025 | 126.74 Mn |
| Sep 30, 2025 | 126.88 Mn |
| Jun 30, 2025 | 126.85 Mn |
| Mar 31, 2025 | 126.30 Mn |
| Dec 31, 2024 | 131.67 Mn |
| Sep 30, 2024 | 132.58 Mn |
| Jun 30, 2024 | 132.57 Mn |
| Mar 31, 2024 | 131.86 Mn |
| Dec 31, 2023 | 131.23 Mn |
| Sep 30, 2023 | 131.31 Mn |
| Jun 30, 2023 | 131.29 Mn |
| Mar 31, 2023 | 131.08 Mn |
| Dec 31, 2022 | 130.07 Mn |
| Sep 30, 2022 | 130.90 Mn |
| Jun 30, 2022 | 129.64 Mn |
| Mar 31, 2022 | 128.79 Mn |
| Dec 31, 2021 | 128.33 Mn |
| Sep 30, 2021 | 128.55 Mn |